Tandem Diabetes Rg
TNDM
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
08/30/2025 - 02:00:00
Bid
08/29/2025 - 21:59:59
Bid
Volume
Ask
08/29/2025 - 21:59:59
Ask
Volume
12.51
+0.72 ( +6.11% )
12.52
1,300
12.53
14,200
More information
Analysis by TheScreener
29.08.2025
Evaluation Slightly negative  
Interest None  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 08.07.2025.
Interest
  None
No stars since 22.08.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 08.08.2025 at a price of 11.23.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Negative
 
The dividend-adjusted forty day technical trend is negative since 17.06.2025.
4wk Rel Perf
  -26.45%
 
The four-week dividend-adjusted underperformance versus SP500 is 26.45%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 1.27%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 5.44%.
Mkt Cap in $bn
  0.85
With a market capitalization <$2bn, TANDEM DIABETES CARE is considered a small-cap stock.
G/PE Ratio
  -0.28
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -130.79
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -36.30%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  100
For 1% of index variation, the stock varies on average by 1.00%.
Correlation
  0.27
Stock movements are strongly independent of index variations.
Value at Risk
  5.78
The value at risk is estimated at USD 5.78. The risk is therefore 46.20%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  05.07.2019